| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1484 | |
| Phytochemical name or plant extracts | 5,7,8,4'-tetramethoxyflavone | |
| PMID | 29117732 | |
| Literature evidence | Biological studies revealed that compound I found to have a good antidiabetic and antiacetylcholinesterase activities meanwhile compounds II, III and V showed a significant free radical scavenging ability as well as antioxidant capacity. | |
| IUPAC name | 5,7,8-trimethoxy-2-(4-methoxyphenyl)chromen-4-one | |
| Phytochemicals’ class or type of plant extracts | Flavonoid | |
| Source of phytochemicals or plant Extracts | Citrus hystrix | |
| Geographical availability | Assam, Bangladesh, Bismarck Archipelago, Borneo, Cambodia, China South-Central, China Southeast, East Himalaya, Lesser Sunda Is., Malaya, Maluku, Myanmar, New Guinea, Nicobar Is., Philippines, Solomon Is., Sulawesi, Sumatera, Thailand, Vanuatu, Vietnam, Wallis-Futuna Is. | |
| Plant parts | Fruits | |
| Other cancers | Breast cancer, Glioma, Lung cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | In addition, compounds I, IV, V and VI showed cytotoxicity against U87, A549 and MCF-7 cells. Overall, the new compound I showed valuable bioactive properties. Compound I is 5,7,8,4?-tetramethoxyflavone | |
| Cell line/ mice model | U87, A549, MCF-7 | |
| Additional information | NA | |
| PubChem ID | 629964 | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:771927-1 | |
| Safety | NA |